Fujian Wanchen Food Group (300972.SZ) re-submitted its application for H-share issuance and listing to the Hong Kong Stock Exchange and published the application materials.
Wanchen Group (300972.SZ) announced that the company has re-submitted the application for issuing overseas listed shares (H shares) and listing on the main board of the Hong Kong Stock Exchange to the Hong Kong Stock Exchange on March 30, 2026. On the same day, the application materials for this issuance and listing were published on the website of the Hong Kong Stock Exchange. The application materials were prepared and published by the company in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange. They are draft versions, and the information contained therein may be updated and revised as appropriate.
Fujian Wanchen Food Group (300972.SZ) announced that the company has re-submitted an application to issue overseas listed shares (H shares) and list on the main board of the Hong Kong Stock Exchange on March 30, 2026. The company has also published the application materials on the Hong Kong Stock Exchange website on the same day. The application materials have been prepared and published in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, and are in draft form. The information contained in the materials may be updated and revised in due course.
Related Articles

FUTURE MACH LTD (01401): Zheng Qichang has resigned as an independent non-executive director.

HANISON (00896): Ma Liqiong resigns as Company Secretary and Authorized Representative

As of the end of March, China Railway (00390) had repurchased a total of 28.812 million A-shares.
FUTURE MACH LTD (01401): Zheng Qichang has resigned as an independent non-executive director.

HANISON (00896): Ma Liqiong resigns as Company Secretary and Authorized Representative

As of the end of March, China Railway (00390) had repurchased a total of 28.812 million A-shares.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


